Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 35.60%38.02B | ---- | -17.59%28.04B | ---- | 30.71%34.02B | ---- | 5.48%26.03B | ---- | 3.75%24.68B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -1.28%-11.86B | ---- | 41.97%-11.71B | ---- | -12.14%-20.18B | ---- | -1.62%-18B | ---- | -4.26%-17.71B |
| Investment loss (gain) | ---- | -270.81%-15.12B | ---- | -210.01%-4.08B | ---- | --3.71B | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -28.81%-7.12B | ---- | -15.76%-5.53B | ---- | -5.59%-4.78B | ---- | -14.50%-4.52B | ---- | 7.04%-3.95B |
| Impairment and provisions: | ---- | -310.39%-911M | ---- | 633.90%433M | ---- | -84.72%59M | ---- | 241.59%386M | ---- | -15.67%113M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.42%118M | ---- | -51.50%113M |
| -Other impairments and provisions | ---- | -310.39%-911M | ---- | 633.90%433M | ---- | -77.99%59M | ---- | --268M | ---- | ---- |
| Asset sale loss (gain): | ---- | 23.64%-84M | ---- | 6.78%-110M | ---- | -6.31%-118M | ---- | -56.34%-111M | ---- | -108.82%-71M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 23.64%-84M | ---- | 6.78%-110M | ---- | -6.31%-118M | ---- | -56.34%-111M | ---- | -108.82%-71M |
| Depreciation and amortization: | ---- | 1.36%3.8B | ---- | 0.89%3.75B | ---- | 6.32%3.72B | ---- | -1.22%3.5B | ---- | 6.15%3.54B |
| -Depreciation | ---- | -3.33%1.77B | ---- | -6.81%1.83B | ---- | 6.38%1.97B | ---- | -3.65%1.85B | ---- | 1.91%1.92B |
| -Amortization of intangible assets | ---- | 16.65%1.11B | ---- | 34.89%955M | ---- | 28.96%708M | ---- | 26.79%549M | ---- | 24.43%433M |
| Financial expense | ---- | 3.65%1.19B | ---- | 14.53%1.15B | ---- | -34.44%1.01B | ---- | -0.90%1.53B | ---- | 8.64%1.55B |
| Exchange Loss (gain) | ---- | 107.21%8M | ---- | 85.38%-111M | ---- | -369.15%-759M | ---- | -54.59%282M | ---- | 906.49%621M |
| Special items | ---- | ---- | ---- | ---- | ---- | 115.73%500M | ---- | -189.17%-3.18B | ---- | -202.75%-1.1B |
| Operating profit before the change of operating capital | ---- | -33.05%7.92B | ---- | -31.11%11.83B | ---- | 190.28%17.17B | ---- | -22.83%5.92B | ---- | 10.06%7.67B |
| Change of operating capital | ||||||||||
| Insurance business receivables (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -259.61%-5.39B | ---- | 129.61%3.38B |
| Insurance liabilities Increase (decrease) | ---- | 58.90%29.08B | ---- | -45.49%18.3B | ---- | 55.86%33.57B | ---- | 340.76%21.54B | ---- | -82.30%4.89B |
| Reinsurance payable Increase (decrease) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -71.38%678M | ---- | -36.71%2.37B |
| Special items for working capital changes | ---- | 497.63%4.02B | ---- | 22.45%-1.01B | ---- | 20.28%-1.31B | ---- | -939.49%-1.64B | ---- | -94.21%195M |
| Cash from business operations | ---- | 40.88%41.03B | ---- | -41.10%29.12B | ---- | 134.24%49.44B | ---- | 14.13%21.11B | ---- | -38.91%18.49B |
| Other taxs | ---- | 46.83%-4.56B | ---- | -27.46%-8.58B | ---- | -41.06%-6.73B | ---- | 16.05%-4.77B | ---- | -27.25%-5.68B |
| Special items of business | 26.57%26.89B | ---- | 20.02%21.25B | ---- | -37.28%17.7B | ---- | 252.50%28.23B | ---- | -47.20%8.01B | ---- |
| Net cash from operations | 26.57%26.89B | 77.51%36.46B | 20.02%21.25B | -51.90%20.54B | -37.28%17.7B | 161.45%42.71B | 252.50%28.23B | 27.52%16.34B | -47.20%8.01B | -50.35%12.81B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 17.07%7.64B | -20.85%11.71B | -25.09%6.53B | 14.25%14.8B | 17.83%8.71B | -31.99%12.95B | 12.94%7.39B | 27.30%19.05B | -10.54%6.55B | 6.96%14.96B |
| Dividend received - investment | 40.16%4.07B | -1.77%6.56B | -33.17%2.9B | -9.53%6.68B | -6.12%4.34B | 57.78%7.38B | 144.92%4.62B | 19.56%4.68B | 15.05%1.89B | 15.06%3.91B |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | -27.38%10.3B | -37.28%3.41B | -2.36%14.18B | 514.09%5.44B | --14.52B |
| Decrease in deposits (increase) | 144.18%9.58B | -209.41%-18.66B | -685.07%-21.68B | 20,653.01%17.06B | -16.38%3.71B | 96.85%-83M | 588.53%4.43B | 59.80%-2.63B | 90.36%-907M | -168.43%-6.55B |
| Sale of fixed assets | -34.73%109M | 32.11%288M | 54.63%167M | 7.39%218M | 369.57%108M | -40.29%203M | -64.06%23M | 116.56%340M | --64M | 86.90%157M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --594M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---980M | ---- | ---- | ---- | ---- | ---- | 85.61%-300M |
| Recovery of cash from investments | 17.83%92.46B | 47.64%170.09B | 42.45%78.47B | -21.59%115.21B | -36.73%55.08B | 18.20%146.93B | 95.88%87.06B | 44.86%124.3B | -2.85%44.45B | -6.14%85.81B |
| Cash on investment | -52.00%-124.98B | -20.37%-194.73B | -5.41%-82.22B | 20.94%-161.77B | 25.71%-78B | -23.32%-204.63B | -91.93%-104.99B | -24.78%-165.93B | 20.84%-54.7B | -18.84%-132.97B |
| Other items in the investment business | 20.18%-530M | -19.73%-2.8B | -7.62%-664M | 55.38%-2.34B | 17.07%-617M | -144.77%-5.24B | -43.35%-744M | 77.52%-2.14B | 81.02%-519M | -169.11%-9.52B |
| Net cash from investment operations | 29.36%-11.66B | -147.49%-27.55B | -147.50%-16.5B | 65.42%-11.13B | -653.28%-6.67B | -294.56%-32.19B | -46.47%1.21B | 72.24%-8.16B | 107.60%2.25B | -3,223.27%-29.39B |
| Net cash before financing | 221.05%15.23B | -5.25%8.92B | -57.00%4.75B | -10.55%9.41B | -62.50%11.04B | 28.66%10.52B | 186.90%29.43B | 149.33%8.18B | 170.97%10.26B | -161.99%-16.58B |
| Cash flow from financing activities | ||||||||||
| Issuance of bonds | ---- | --11.99B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8B |
| Interest paid - financing | -9.03%-604M | -5.10%-1.11B | 13.17%-554M | -18.59%-1.06B | 1.54%-638M | 49.69%-893M | 19.60%-648M | -58.06%-1.78B | -333.33%-806M | 32.39%-1.12B |
| Dividends paid - financing | ---- | -45.81%-15.5B | ---- | -17.44%-10.63B | ---- | -8.52%-9.05B | ---- | 18.65%-8.34B | ---- | -69.49%-10.25B |
| Absorb investment income | 106.09%12M | ---175M | ---197M | ---- | ---- | -28.45%171M | -88.70%13M | -90.50%239M | --115M | --2.52B |
| Issuance expenses and redemption of securities expenses | ---8B | ---- | ---- | ---- | ---- | ---- | ---- | ---15B | ---- | ---- |
| Other items of the financing business | -725.84%-8.57B | 76.93%-386M | 111.26%1.37B | -145.16%-1.67B | 46.10%-12.17B | -58.64%3.71B | -200.00%-22.58B | -26.99%8.96B | -246.49%-7.53B | 209.15%12.27B |
| Net cash from financing operations | -6,243.90%-17.63B | 57.46%-6.05B | 102.18%287M | -103.27%-14.22B | 44.06%-13.19B | 58.46%-7B | -174.29%-23.59B | -261.83%-16.85B | -168.22%-8.6B | 137.09%10.41B |
| Effect of rate | -157.14%-4M | -85.71%7M | -94.35%7M | -84.24%49M | -34.04%124M | 380.18%311M | 454.72%188M | 29.75%-111M | -223.26%-53M | -495.00%-158M |
| Net Cash | -147.67%-2.4B | 159.61%2.87B | 333.07%5.03B | -236.48%-4.81B | -136.94%-2.16B | 140.67%3.53B | 252.26%5.84B | -40.47%-8.67B | 189.72%1.66B | -368.49%-6.17B |
| Begining period cash | 17.44%19.36B | -22.41%16.49B | -22.41%16.49B | 22.03%21.25B | 22.03%21.25B | -33.51%17.41B | -33.51%17.41B | -19.46%26.19B | -19.46%26.19B | -3.78%32.52B |
| Cash at the end | -21.22%16.96B | 17.44%19.36B | 12.03%21.53B | -22.41%16.49B | -18.05%19.22B | 22.03%21.25B | -15.66%23.45B | -33.51%17.41B | -9.49%27.8B | -19.46%26.19B |
| Cash balance analysis | ||||||||||
| Bank deposits | ---- | ---- | ---- | ---- | ---- | ---- | --11.29B | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --11.29B | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Hua Ming Certified Public Accountants (Special General Partnership), Ernst & Young Accounting Firm | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.